HKD17.08
0.93% yesterday
Hong Kong, Nov 15, 09:08 am CET
ISIN
KYG549581067
Symbol
3692
Index
Sector
Industry

Hansoh Pharmaceutical Group Company Target price 2024 - Analyst rating & recommendation

Hansoh Pharmaceutical Group Company Classifications & Recommendation:

Buy
91%
Hold
9%

Hansoh Pharmaceutical Group Company Price Target

Target Price HKD23.06
Price HKD17.08
Potential
Number of Estimates 22
22 Analysts have issued a price target Hansoh Pharmaceutical Group Company 2025 . The average Hansoh Pharmaceutical Group Company target price is HKD23.06. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 22 analysts: 20 Analysts recommend Hansoh Pharmaceutical Group Company to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Hansoh Pharmaceutical Group Company stock has an average upside potential 2025 of . Most analysts recommend the Hansoh Pharmaceutical Group Company stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Billion HKD 11.16 13.08
2.33% 17.18%
EBITDA Margin 30.46% 37.93%
5.02% 24.54%
Net Margin 32.42% 34.63%
16.89% 6.81%

22 Analysts have issued a sales forecast Hansoh Pharmaceutical Group Company 2024 . The average Hansoh Pharmaceutical Group Company sales estimate is

HKD13.1b
Unlock
. This is
0.06% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD13.7b 4.54%
Unlock
, the lowest is
HKD12.5b 4.43%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 HKD11.2b 2.33%
2024
HKD13.1b 17.18%
Unlock
2025
HKD13.4b 2.60%
Unlock
2026
HKD14.9b 11.26%
Unlock
2027
HKD18.2b 22.10%
Unlock
2028
HKD23.2b 27.32%
Unlock

19 Analysts have issued an Hansoh Pharmaceutical Group Company EBITDA forecast 2024. The average Hansoh Pharmaceutical Group Company EBITDA estimate is

HKD5.0b
Unlock
. This is
2.57% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
HKD6.0b 18.47%
Unlock
, the lowest is
HKD4.1b 18.58%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 HKD3.4b 2.81%
2024
HKD5.0b 45.93%
Unlock
2025
HKD4.7b 5.77%
Unlock
2026
HKD5.4b 14.55%
Unlock

EBITDA Margin

2023 30.46% 5.02%
2024
37.93% 24.54%
Unlock
2025
34.83% 8.17%
Unlock
2026
35.87% 2.99%
Unlock

11 Hansoh Pharmaceutical Group Company Analysts have issued a net profit forecast 2024. The average Hansoh Pharmaceutical Group Company net profit estimate is

HKD4.5b
Unlock
. This is
11.23% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD4.9b 4.17%
Unlock
, the lowest is
HKD3.6b 29.48%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 HKD3.6b 19.61%
2024
HKD4.5b 25.15%
Unlock
2025
HKD4.1b 10.06%
Unlock
2026
HKD4.5b 11.59%
Unlock
2027
HKD5.7b 26.27%
Unlock
2028
HKD9.8b 71.03%
Unlock

Net Margin

2023 32.42% 16.89%
2024
34.63% 6.81%
Unlock
2025
30.36% 12.33%
Unlock
2026
30.45% 0.30%
Unlock
2027
31.49% 3.42%
Unlock
2028
42.30% 34.33%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share HKD 0.61 0.76
19.61% 24.59%
P/E 22.37
EV/Sales 5.83

11 Analysts have issued a Hansoh Pharmaceutical Group Company forecast for earnings per share. The average Hansoh Pharmaceutical Group Company <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

HKD0.76
Unlock
. This is
11.63% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
HKD0.82 4.65%
Unlock
, the lowest is
HKD0.61 29.07%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 HKD0.61 19.61%
2024
HKD0.76 24.59%
Unlock
2025
HKD0.69 9.21%
Unlock
2026
HKD0.77 11.59%
Unlock
2027
HKD0.97 25.97%
Unlock
2028
HKD1.65 70.10%
Unlock

P/E ratio

Current 19.84 31.66%
2024
22.37 12.75%
Unlock
2025
24.87 11.18%
Unlock
2026
22.29 10.37%
Unlock
2027
17.65 20.82%
Unlock
2028
10.32 41.53%
Unlock

Based on analysts' sales estimates for 2024, the Hansoh Pharmaceutical Group Company stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.82 2.84%
2024
5.83 0.13%
Unlock
2025
5.68 2.53%
Unlock
2026
5.11 10.12%
Unlock
2027
4.18 18.10%
Unlock
2028
3.28 21.46%
Unlock

P/S ratio

Current 7.74 2.13%
2024
7.75 0.06%
Unlock
2025
7.55 2.53%
Unlock
2026
6.79 10.12%
Unlock
2027
5.56 18.10%
Unlock
2028
4.37 21.46%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today